Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A looking glass perspective: thalidomide and cyclopamine.

W Gaffield1, J P Incardona, R P Kapur

  • 1Western Regional Research Center, ARS, USDA, Albany CA 94710, USA. wg@pw.usda.gov

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|October 8, 1999
PubMed
Summary

Toxic compounds like thalidomide and cyclopamine can become valuable medicines. Cyclopamine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyaromatic hydrocarbons in pollution: a heart-breaking matter.

The Journal of physiology·2019
Same author

Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.

Pediatric surgery international·2017
Same author

Zebrafish and clean water technology: assessing soil bioretention as a protective treatment for toxic urban runoff.

The Science of the total environment·2014
Same author

Counting neurons is not as easy as 'one-two, three'.

Neurogastroenterology and motility·2013
Same author

Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal tract--report on behalf of the Gastro 2009 International Working Group.

Neurogastroenterology and motility·2010
Same author

Histological analysis of DuraGen in a human subject: case report.

Clinical neuropathology·2008

Area of Science:

  • Medicinal Chemistry
  • Developmental Biology
  • Pharmacology

Background:

  • Many toxic compounds possess beneficial biological activities.
  • Thalidomide, initially known for teratogenicity, is now a valuable therapeutic agent.
  • Cyclopamine, a plant teratogen, exhibits recently discovered therapeutic potential.

Purpose of the Study:

  • To highlight the dual nature of toxic compounds as therapeutic leads.
  • To explore cyclopamine's potential in drug development.
  • To understand cyclopamine's role in Sonic hedgehog signaling.

Main Methods:

  • Review of existing literature on thalidomide and cyclopamine.
  • Analysis of cyclopamine's biochemical properties.
  • Investigation of Sonic hedgehog pathway inhibition.

Main Results:

  • Cyclopamine inhibits Sonic hedgehog signal transduction.
  • This inhibition offers insights into organogenesis.
  • Cyclopamine serves as a potential lead compound for drug development.

Conclusions:

  • Compounds initially recognized for toxicity can be repurposed for medicinal use.
  • Cyclopamine's inhibition of Sonic hedgehog signaling presents therapeutic opportunities.
  • Further research into cyclopamine may yield new drug candidates.

Related Experiment Videos